Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle stock (NYSE: ALB) jumped around 8–9% on November 17, 2025, as lithium prices hit a one‑year high and Argus raised its price target to $140. Here’s what’s driving the move, how Wall Street is reacting, and what it could mean for investors. Albemarle stock is on fire today Albemarle stock has been in rally mode for days, but today’s move stands out even in a strong November run. German market outlet wallstreet‑online describes today’s advance as a “kräftiger Gewinn” (strong gain), pointing out that: wallstreet-online.de In other words, today is not a random pop – it’s part of a
17 November 2025
Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

As of mid-afternoon on November 17, 2025, Canadian Solar Inc. (CSIQ) is trading around $29–30 per share, after an extremely volatile few sessions that saw the stock spike to the mid‑$30s following its Q3 2025 earnings release. MarketBeat 1. Stock performance: from laggard to November high‑flyer Canadian Solar has turned into one of November’s surprise momentum stories: Today’s action looks more like consolidation after a huge run: the real story on November 17 is in the newsflow around battery storage, analyst calls and insider activity, rather than another big price spike. 2. Q3 2025 earnings: revenue and margin beat, but
Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

On Monday, November 17, 2025, Clearwater Analytics Holdings, Inc. (NYSE: CWAN) once again jumped onto traders’ radar as renewed buyout speculation from private equity giants Warburg Pincus and Permira pushed the stock sharply higher in pre‑market trading and kept it among the day’s notable movers. TradingView+2Benzinga+2 Below is a full rundown of what’s driving Clearwater Analytics today, how it fits into the company’s broader AI and growth story, and what investors are watching next. CWAN Stock Today: Double‑Digit Premarket Spike, Still Volatile Mid‑Session Clearwater Analytics shares extended last week’s rally in Monday’s pre‑market session: By late morning, the move had
17 November 2025
E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

On November 17, 2025, Sinclair Inc. disclosed an 8.2% stake in The E.W. Scripps Company (NASDAQ: SSP) and confirmed it is pursuing a merger, sending SSP stock more than 20% higher. Here’s what the potential Sinclair–Scripps deal means for investors, the local TV landscape and sports rights. The E.W. Scripps Company (NASDAQ: SSP) is at the center of one of the biggest media storylines of 2025 after rival broadcaster Sinclair Inc. (NASDAQ: SBGI) revealed it has quietly built an 8.2% stake in Scripps’ Class A non‑voting shares and is actively pushing for a takeover.Reuters+1 The disclosure, made in a regulatory
Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust, Inc. (NYSE: MPW) is back in the headlines today after announcing a 12% increase to its regular quarterly dividend, alongside updates that underscore its ongoing recovery story and capital-return strategy. On November 17, 2025, the healthcare REIT said its board has approved a quarterly cash dividend of $0.09 per share, up from $0.08 last quarter. The dividend will be paid on January 8, 2026 to shareholders of record as of December 11, 2025. Business Wire+2MarketScreener+2 The move comes just weeks after MPW reported third-quarter results, unveiled a $150 million common stock repurchase program, and continued to reshape
17 November 2025
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics Inc. (NASDAQ: RPTX) is back in the spotlight today after investors digested last week’s surprise acquisition agreement with XenoTherapeutics, Inc., a Massachusetts-based non‑profit biotech. The stock is trading sharply higher and unusually active as the market prices in a mostly cash takeover and a complex contingent value right (CVR) structure that could unlock additional upside over the coming decade. Repare Therapeutics+1 As of this afternoon’s session, RPTX is changing hands around the low‑$2 range, not far above the estimated US$1.82 per‑share cash consideration embedded in the deal, and up close to 30% versus pre‑announcement levels, reflecting a classic
Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems Ltd. (NASDAQ: ESLT; TASE: ESLT) is back in the global spotlight today after announcing a massive $2.3 billion international defense contract, sending the stock sharply higher just one day before its third‑quarter 2025 earnings report. The deal, disclosed via a company press release that was also filed with the U.S. Securities and Exchange Commission on Form 6‑K, covers a long‑term “strategic solution” to be delivered over eight years, with the customer and exact systems undisclosed. MarketScreener At the same time, Elbit is in the news for new deliveries to the British Army, fresh institutional buying of ESLT shares,
Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Chilean lithium giant jumps ~12% on Monday as big funds buy in, lithium prices spike on China optimism, and investors brace for Q3 2025 earnings. Sociedad Química y Minera de Chile S.A. (NYSE: SQM) is back in the spotlight. By late morning on Monday, SQM’s New York–listed shares were up roughly 11–12% around $61, hitting fresh 52‑week highs and extending a sharp rally that began after China cleared its landmark lithium joint venture with state miner Codelco.MarketBeat+1 Today’s surge comes as: Here’s what’s driving SQM today – and what to watch next. 1. Big funds are quietly loading up on
17 November 2025
PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (NYSE: PACS) jumps more than 40–50% after announcing plans to file all overdue SEC reports and release Q3 2025 earnings on November 19, easing delisting and default fears for the nursing-home giant. Shares of PACS Group, Inc. (NYSE: PACS) exploded higher on Monday after the post‑acute care operator said it will finally clear a months‑long SEC reporting backlog this week, a move seen as critical to keeping its New York Stock Exchange listing and stabilizing its financing. By late morning, PACS stock was trading around $15.90, up roughly 50% on the day and rebounding from a bruising slide
17 November 2025
ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) is back in the spotlight today, November 17, 2025, as the stock trades sharply higher while fresh institutional buying, surging options activity and a looming earnings release collide in a single, high‑volatility narrative. As of late morning U.S. trading, ZIM shares are changing hands around $17.0, up roughly 6–6.5% on the day, with an intraday range near $16.54–$17.50 and a 52‑week band of about $11–$29. Investing.com+1 At the same time, a new filing shows Bulltick Wealth Management LLC has significantly increased its position, options markets are pricing an ≈12% move around Thursday’s earnings
17 November 2025
Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes

Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes

Lucid Group, Inc. (NASDAQ: LCID) is under intense pressure today as its share price sinks to a new all‑time low, capping a brutal two‑week slide driven by weak earnings, fresh debt, analyst downgrades and ongoing concerns about cash burn at the Saudi‑backed EV maker. By late morning on Monday, Lucid stock was trading around $13.31, down more than 6% on the day and extending a steep decline of over 35% since mid‑October, according to real‑time data from Investing.com.Investing.com The move pushes LCID to fresh 52‑week lows and, according to several market outlets, to the lowest level since the company went
Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer Inc. (NYSE: PFE) is back in the headlines today with a flurry of developments that span new product launches, obesity-drug M&A, fresh vaccine data and ongoing debate about whether its battered stock is finally a buy. As of this afternoon, Pfizer shares are trading around $25.28, little changed on the day, and still down roughly 55% from their late‑2022 peak, leaving the dividend yield near the 7% level that has attracted income‑focused investors.sharewise.com+1 Below is a breakdown of the key Pfizer news and stock drivers for November 17, 2025. Market snapshot: PFE on November 17, 2025 Short‑term quantitative models
1 36 37 38 39 40 233

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop